CardioDx is a cardiovascular genomic diagnostics company located in Palo Alto, CA. CardioDx develops clinically validated genomic tests to aid in assessing and tailoring care of individuals with cardiovascular disease, including coronary artery disease (CAD), cardiac arrhythmias, and heart failures.
Current Team (11)Update
Funding Rounds (7) - $229MUpdate
Board Members and Advisors (5)Update
Venture Capital Firm
venture capital firm
At Pappas Ventures, their sole focus is investing in the life sciences â€“ biotechnology,...
Bright Capital is a venture capital firm, notable for its merchant venturing approach and global...
For 30 years the Mohr Davidow Ventures (MDV) team has invested in early stage technology-based...
Acadia Woods Partners is a New York based investment partnership that focuses primarily on early...
Asset Management was founded in 1965 by legendary venture capitalist Franklin Pitch Johnson,...
The DAG (Duff Ackerman & Goodrich) Ventures partnership began with investments in the cable...
2500 Faber Place
Palo Alto, CA 94303